MX2022004742A - Derivados del acido carboxilico de quinolona. - Google Patents

Derivados del acido carboxilico de quinolona.

Info

Publication number
MX2022004742A
MX2022004742A MX2022004742A MX2022004742A MX2022004742A MX 2022004742 A MX2022004742 A MX 2022004742A MX 2022004742 A MX2022004742 A MX 2022004742A MX 2022004742 A MX2022004742 A MX 2022004742A MX 2022004742 A MX2022004742 A MX 2022004742A
Authority
MX
Mexico
Prior art keywords
sub
quinolone carboxylic
carboxylic derivatives
stereoisomer
prodrug
Prior art date
Application number
MX2022004742A
Other languages
English (en)
Inventor
Chu - Chung LIN
Hung - Chuan Chen
Chiayn Chiang
Chih - Ming Chen
Original Assignee
Taigen Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taigen Biotechnology Co Ltd filed Critical Taigen Biotechnology Co Ltd
Publication of MX2022004742A publication Critical patent/MX2022004742A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)

Abstract

Un compuesto de fórmula (I) a continuación, o una de sus sales, estereoisómeros, solvatos o profármacos farmacéuticamente aceptables: (ver Fórmula) (I), en donde R1, R2, R3, R5, R6 y R7 se definen como en la sección breve descripción de la invención, además, se describe un método para usar el compuesto, sal, estereoisómero, solvato o profármaco descritos anteriormente para el tratamiento infecciones microbianas y una composición farmacéutica que contiene la misma.
MX2022004742A 2019-10-23 2020-10-23 Derivados del acido carboxilico de quinolona. MX2022004742A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962924763P 2019-10-23 2019-10-23
PCT/US2020/056966 WO2021081267A1 (en) 2019-10-23 2020-10-23 Quinolone carboxylic derivatives

Publications (1)

Publication Number Publication Date
MX2022004742A true MX2022004742A (es) 2022-05-16

Family

ID=75620835

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022004742A MX2022004742A (es) 2019-10-23 2020-10-23 Derivados del acido carboxilico de quinolona.

Country Status (10)

Country Link
US (1) US20240101527A1 (es)
EP (1) EP4048663A4 (es)
KR (1) KR20220080176A (es)
CN (1) CN114008031A (es)
AU (1) AU2020369579A1 (es)
CA (1) CA3158628A1 (es)
IL (1) IL291981A (es)
MX (1) MX2022004742A (es)
TW (1) TW202128645A (es)
WO (1) WO2021081267A1 (es)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0366189A3 (en) * 1988-10-24 1992-01-02 Norwich Eaton Pharmaceuticals, Inc. Novel antimicrobial lactam-quinolones
BR9812644B1 (pt) * 1997-09-15 2010-07-13 quinolonas antimicrobianas, composição farmacêutica e uso das mesmas.
DE19962470A1 (de) * 1999-12-22 2001-07-12 Schulz Hans Herrmann Verwendung von Chemotherapeutika
WO2011101710A1 (en) * 2010-02-16 2011-08-25 Wockhardt Research Centre Efflux pump inhibitors
AU2007339692B2 (en) * 2007-01-05 2012-01-19 Daiichi Sankyo Company, Limited Fused substituted aminopyrrolidine derivative
CN103467448B (zh) * 2013-09-18 2015-04-15 浙江司太立制药股份有限公司 7-(3-氨基-4-烷氧亚胺基-1-哌啶基)-1-[(1r,2s)-2-氟环丙基]喹诺酮羧酸类化合物及其制备方法

Also Published As

Publication number Publication date
AU2020369579A1 (en) 2022-04-14
CN114008031A (zh) 2022-02-01
EP4048663A4 (en) 2023-08-30
WO2021081267A1 (en) 2021-04-29
EP4048663A1 (en) 2022-08-31
KR20220080176A (ko) 2022-06-14
IL291981A (en) 2022-06-01
US20240101527A1 (en) 2024-03-28
CA3158628A1 (en) 2021-04-29
TW202128645A (zh) 2021-08-01

Similar Documents

Publication Publication Date Title
JOP20220155A1 (ar) مشتقات البيرازول مفيدة كعوامل مضادة للسرطان
MX2022008066A (es) Compuestos triciclicos sustituidos.
MX2021000887A (es) Compuestos espiroheterociclicos y metodos de uso de los mismos para el tratamiento de cancer.
MX2022006475A (es) Compuestos triciclicos sustituidos.
CA3057882A1 (en) Substituted dihydro-spiro-napthalene-oxa derivatives and pharmaceutical compositions thereof useful as inhibitors of mcl-1 protein
MX2021013075A (es) Oxisteroles y metodos de uso de los mismos.
MX2020000268A (es) Agonista de fxr.
JO3588B1 (ar) مشتقات 3-تترازوليل -بنزين- 1، 2-ثنائي سلفوناميد كمثبطات ميتالو -بيتا- لاكتاماز
EP3693369A3 (en) Bromodomain inhibitors
IN2012DN03085A (es)
WO2020257549A3 (en) Compounds for treatment of pd-l1 diseases
MX2020009530A (es) Inhibidores de la o-glicoproteína-2-acetamido-2-desoxi-3-dglicopir anosidasa.
TN2019000170A1 (en) Tetracyclic heterocycle compounds useful as hiv integrase inhibitors
WO2018209363A3 (en) PROPIONIC ACID DERIVATIVES AND ASSOCIATED METHODS OF USE
MX2020013694A (es) Compuestos heterocíclicos como inhibidores de trk.
MX2023008954A (es) Inhibidores de los receptores erbb.
MX2021011118A (es) Derivados de azolopiridina macrocíclicos como moduladores de eed y prc2.
WO2018183089A8 (en) Compositions for treating and/or preventing cancer
MX2020011317A (es) Compuestos heterociclicos triciclicos utiles como inhibidores de la integrasa de vih.
MX2022004451A (es) Heteroaril-bifenil-amidas para el tratamiento de enfermedades relacionadas con el ligando pd-l1.
WO2019168688A3 (en) Quinolone analogs and their salts, compositions, and method for their use
WO2018035346A8 (en) KINASE INHIBITING COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING CANCER
MX2021003686A (es) Medicamento para el tratamiento de la tos cronica.
MX2022004450A (es) Aminas de heteroaril-bifenilo para el tratamiento de enfermedades pd-l1.
MX2021012105A (es) Compuestos de pirrol.